ストックスクリーナーアプリを入手
1.58
3.95%
0.06
プレマーケット:
1.56
-0.02
-1.27%
前日終値:
$1.52
開ける：
$1.52
24時間の取引高:
31,460
Relative Volume:
2.05
時価総額：
$84.49M
収益：
$118.18M
当期純損益:
$5.99M
株価収益率:
11.98
EPS:
0.1319
ネットキャッシュフロー:
$-12.91M
1週間 パフォーマンス:
+1.94%
1か月 パフォーマンス:
+3.95%
6か月 パフォーマンス:
-8.42%
1年 パフォーマンス:
-31.30%
1日の値動き範囲:
$1.49
$1.59
1週間の範囲:
$1.48
$1.59
52週間の値動き範囲:
$1.17
$2.62
Intercure Ltd Stock (INCR) Company Profile
INCR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.58 | 84.49M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
147.37 | 69.30B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 47.50B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.53 | 44.47B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.83B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
293.12 | 13.43B | 2.99B | 1.21B | 1.13B | 25.06 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-05-18 | アップグレード | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd (INCR) 最新ニュース
How InterCure Ltd. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
What analysts say about InterCure Ltd. stockFree Stock Selection - PrintWeekIndia
What drives InterCure Ltd. stock priceFree Predictions - PrintWeekIndia
Is InterCure Ltd. a good long term investmentHigh-impact stock picks - jammulinksnews.com
InterCure Ltd. Stock Analysis and ForecastPowerful market insights - jammulinksnews.com
InterCure (NASDAQ:INCR) Shares Down 3.5% – Here’s What Happened - Defense World
What makes InterCure Ltd. stock price move sharply2x Return Forecast - newser.com
Why InterCure Ltd. stock attracts strong analyst attentionSmart Money Signals - Newser
InterCure (NASDAQ:INCR) Stock Price Up 1.9% – What’s Next? - Defense World
InterCure And Cookies Successfully Launch Flagship Pharmacy In Be'er Sheva, Israel - Barchart.com
InterCure (NASDAQ:INCR) Shares Down 4.4% – What’s Next? - Defense World
InterCure Reports FY2024 Results - mg Magazine
InterCure Reports Strong Start to 2025 Amid Recovery Efforts - TipRanks
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PR Newswire
Intercure Ltd. Delays Yearly Report Filing - TipRanks
Interbusiness, Virdis partner to distribute Intercure products - Rubber News
InterCure (NASDAQ:INCR) Stock Price Down 3.4% – Time to Sell? - Defense World
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - GuruFocus.com
InterCure (NASDAQ:INCR) Shares Down 0.7%What's Next? - MarketBeat
InterCure Announces Leadership Change and Secures $18.2 Million Financing - TipRanks
InterCure Secures Massive $48M War Recovery Fund: CEO Takes Helm in Strategic Leadership Shift - Stock Titan
Short Interest in InterCure Ltd. (NASDAQ:INCR) Expands By 96.2% - MarketBeat
Jane Street Group LLC Acquires New Stake in InterCure Ltd. (NASDAQ:INCR) - Defense World
InterCure (NASDAQ:INCR) Trading Up 3.7% – Should You Buy? - Defense World
Cannabis co InterCure raising NIS 66m for Nir Oz facilityGlobes - Globes - Israel Business News
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PR Newswire
Synbiotic's CAGR Forecast at 80%, ECS Botanics to Expand Footprint in Germany, & More from Intercure - Business of Cannabis
Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Market Exclusive
InterCure nears break even in first half of 2024, despite ongoing Israel-Hamas war - Crain's Chicago Business
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewswire
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Yahoo Finance
IM Cannabis Merger Scrapped, Cel AI Gets a New CEO, & More from Intercure - Business of Cannabis
Analyst: Israel’s InterCure paving path to big gains - Green Market Report
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference - Business Wire
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million - Business Wire
InterCure: Bargain Israel Cannabis Play (NASDAQ:INCR) - Seeking Alpha
InterCure Announces Preliminary Estimated 2023 Revenue of NIS 351 million and EBITDA of over NIS 50 million - Business Wire
symbol__ Stock Quote Price and Forecast - CNN
InterCure Congratulates Germany on Cannabis Reform, Expanding its Global Footprint - Business Wire
InterCure Provides Update Regarding Nir Oz Facility in Israel - Cannabis Business Times
InterCure Provides an Update Regarding Nir Oz Facility - GlobeNewswire
InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain - GlobeNewswire
InterCure Wins Cannolam Arbitration Proceeding - Yahoo Finance
Intercure Ltd (INCR) 財務データ
収益
当期純利益
現金流量
EPS
1.97%
0.68%
大文字化:
|
ボリューム (24 時間):